Litcius/Paper detail

New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer

Nicolas Girard

2022Current Treatment Options in Oncology37 citationsDOI

Topics & Concepts

OsimertinibMedicineLung cancerOncologyClinical trialEpidermal growth factor receptorImmunotherapyTargeted therapyInternal medicineErlotinibCancerLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesGastric Cancer Management and Outcomes
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer | Litcius